![](/img/cover-not-exists.png)
Interference with ER-α enhances the therapeutic efficacy of the selective CDK inhibitor roscovitine towards ER-positive breast cancer cells
Józefa Węsierska-Gądek, David Gritsch, Nora Zulehner, Oxana Komina, Margarita MaurerVolume:
112
Year:
2011
Language:
english
Pages:
15
DOI:
10.1002/jcb.23024
File:
PDF, 1.31 MB
english, 2011